BerganKDV Wealth Management’s ImmunityBio IBRX Stock Holding History

BerganKDV Wealth Management’s Portfolio IBRX Stock Details IBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$320	Hold	115	–	–	﹤0.01%	835
2023 Q1	$210	Hold	115	–	–	﹤0.01%	1028
2022 Q4	$583	Hold	115	–	–	﹤0.01%	939
2022 Q3	$1K	Hold	115	–	–	﹤0.01%	897
2022 Q2	$0	Hold	115	–	–	﹤0.01%	1008
2022 Q1	$1K	Hold	115	–	–	﹤0.01%	932
2021 Q4	$1K	Hold	115	–	–	﹤0.01%	990
2021 Q3	$1K	Hold	115	–	–	﹤0.01%	975
2021 Q2	$2K	Buy	+115	New	+$1.9K	﹤0.01%	819
2021 Q1	–	Sell	-34	Closed	–	–	966
2020 Q4	$0	Buy	+34	New	+$327	﹤0.01%	976

Other funds holding IBRX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Allen Holding New York $1.01B AUM 27.61% 1-Year Est. Return

BerganKDV Wealth Management's IBRX Position: Q2 2023 in Review

BerganKDV Wealth Management held its ImmunityBio (IBRX) position steady in Q2 2023 at 115 shares worth $320. The position accounts for ﹤0.01% of the portfolio, ranked #835.

BerganKDV Wealth Management first reported a position in IBRX in Q4 2020 and has held it in 10 quarters since. The position peaked at $2K in Q2 2021. 117 funds tracked by Wall St. Rank hold IBRX as of Q2 2023.

BerganKDV Wealth Management held 115 shares of ImmunityBio worth $320 as of Q2 2023.
BerganKDV Wealth Management left its ImmunityBio share count unchanged in Q2 2023.
ImmunityBio made up ﹤0.01% of BerganKDV Wealth Management's portfolio in Q2 2023, its #835 holding.
BerganKDV Wealth Management first reported a position in ImmunityBio in Q4 2020 and has held it in 10 quarters since.
BerganKDV Wealth Management's ImmunityBio position peaked at $2K in Q2 2021.
117 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2023.

Based on BerganKDV Wealth Management's 13F filing for Q2 2023, filed 24 Jul 2023.